“The Predicting Effect of ASXL1 Mutation on BCR-ABL Transcript Types and Responses to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia”. Medical Forum Monthly, vol. 36, no. 8, Sept. 2025, https://doi.org/10.60110/medforum.360805.